Physician profile
John E Barrett
NPI 1154328557
$5,350.40
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,686 · 2020: $89.64 · 2021: $121 · 2022: $1,417 · 2023: $35.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $3,423.66 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mid-Atlantic Surgical Systems, LLC | $1,227.02 | 2022 | |
| Treace Medical Concepts, INC. | $154.06 | 2019-2023 | |
| Smith+Nephew, INC. | $106.74 | 2019-2022 | |
| Horizon Therapeutics Plc | $93.89 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $85.90 | 2019 | |
| Misonix INC | $72.32 | 2020 | |
| 3m Company | $55.25 | 2019 | |
| Polynovo North America LLC | $29.85 | 2022 | |
| Convatec INC. | $23.91 | 2019 | |
| Terumo Bct, INC. | $21.20 | 2019 | |
| In2bones USA, LLC | $15.65 | 2019 | |
| Orthofix Medical, INC. | $14.73 | 2019 | |
| Arteriocyte Medical Systems, INC. | $13.23 | 2022 | |
| Arthrosurface Incorporated | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.